Citracal Regular 250 mg + D Interactions
There are 284 drugs known to interact with Citracal Regular 250 mg + D (calcium / vitamin d), along with 11 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 18 are major, 222 are moderate, and 44 are minor.
- View all 284 medications that may interact with Citracal Regular 250 mg + D
- View Citracal Regular 250 mg + D alcohol/food interactions (2)
- View Citracal Regular 250 mg + D disease interactions (11)
Most frequently checked interactions
View interaction reports for Citracal Regular 250 mg + D (calcium / vitamin d) and the medicines listed below.
- alprazolam
- Ambien (zolpidem)
- Aspirin Low Strength (aspirin)
- azelastine nasal
- Carafate (sucralfate)
- Celebrex (celecoxib)
- Coreg (carvedilol)
- Coumadin (warfarin)
- Cymbalta (duloxetine)
- Effexor XR (venlafaxine)
- ferrous sulfate
- Fish Oil (omega-3 polyunsaturated fatty acids)
- furosemide
- gabapentin
- Gaviscon Regular Strength Tablets (aluminum hydroxide / magnesium trisilicate)
- Glucosamine & Chondroitin with MSM (chondroitin / glucosamine / methylsulfonylmethane)
- hydrocodone
- ibuprofen
- lisinopril
- meloxicam
- metoprolol
- multivitamin
- omeprazole
- pantoprazole
- pravastatin
- ranitidine
- simvastatin
- Synthroid (levothyroxine)
- Tylenol (acetaminophen)
- Vitamin D3 (cholecalciferol)
Citracal Regular 250 mg + D alcohol/food interactions
There are 2 alcohol/food interactions with Citracal Regular 250 mg + D (calcium / vitamin d).
Citracal Regular 250 mg + D disease interactions
There are 11 disease interactions with Citracal Regular 250 mg + D (calcium / vitamin d) which include:
- cardiovascular adverse effects
- phosphate calcifications
- cardiac contraction/conduction
- malabsorption
- renal dysfunction
- sarcoidosis
- arrhythmia
- electrolyte imbalance
- hypercalcemia
- renal dysfunction
- hepatobiliary dysfunction
Report options
More about Citracal Regular 250 mg + D (calcium / vitamin d)
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Prolia
Prolia (denosumab) is an injection that is administered subcutaneously (under the skin) once every ...
Fosamax
Fosamax (alendronate) is used to treat or prevent postmenopausal osteoporosis and steroid-induced ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Premarin
Premarin is used to treat symptoms of menopause such as hot flashes, and vaginal dryness. Learn ...
Reclast
Reclast (zoledronic acid) is used to treat osteoporosis in women after menopause and also to treat ...
Zometa
Zometa is used to treat high blood levels of calcium caused by cancer and multiple myeloma. Learn ...
Tymlos
Tymlos (abaloparatide) is used to treat osteoporosis in men and postmenopausal women who have a ...
Ibandronate
Ibandronate is used for osteoporosis, prevention of osteoporosis
Raloxifene
Raloxifene is used for breast cancer, prevention, osteoporosis, prevention of osteoporosis
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.